Pfizer Biontech Vaccine

FDA approves First RSV vaccine for adults under 60

FDA expands Pfizer’s RSV vaccine label to include all high-risk adults

Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV in high-risk adults aged over 18 years.

Reuters on MSN · 2d

US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease

The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of the disease.

Wall Street Journal · 1d

Pfizer Receives Expanded FDA Approval for RSV Vaccine

Abrysvo is the first vaccine for the respiratory syncytial virus that is indicated for adults younger than 50, the drugmaker said.

CDC Lowers Age for First Pneumococcal Vaccine

U.S. News & World Report · 1d

US CDC Recommends Expanding Pneumococcal Vaccines to Adults Aged 50-64

The U.S. Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The agency's earlier recommendation for vaccination was for adults 65 years or older and children younger than 5,

Reuters on MSN · 1d

US CDC advisers recommend expanding pneumococcal vaccine to adults aged 50-64

(Reuters) -Advisers to the Centers for Disease Control and Prevention on Wednesday recommended expanding the use of vaccines to adults between 50-64 years to protect against pneumococcal disease. The CDC currently recommends all children younger than 5 and all adults 65 years or older get vaccinated for the disease.

San Francisco Examiner · 43m

CDC Lowers Age for First Pneumococcal Vaccine to 50

The CDC on Wednesday lowered the recommended age for a first pneumococcal vaccine to 50, down from 65. The vaccine protects against a range of bacterial illnesses such as pneumoni

2don MSN

Q&A on the 2024-2025 COVID-19 Vaccines

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Does the updated Pfizer COVID-19 vaccine protect against the XEC variant?

Watch Toronto's #1 morning show for the latest news, weather and traffic from across the GTA.

14h

A Pfight At Pfizer

There's some rumbling going on within Pfizer's investment community, as an activist hedge fund says that the company's ...

FDA asks Texas court to shut down COVID-19 vaccine records lawsuit

The U.S. Food and Drug Administration has asked a federal judge in Texas to throw out a public records lawsuit related to ...

FiercePharma9d

GSK takes mRNA patent fight to Moderna, suing over vaccines for COVID and RSV

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK ...

infectiousdiseaseadvisor.com1d

COVID-19 2024 to 2025 Vaccines, for Everyone 6 Months and Older, Target New Strains

COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

2don MSN

Is the system letting down people who were harmed by Covid vaccines?

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, ...

Northwestern sues Moderna for patent infringement over COVID-19 vaccines

Moderna was hit with a new patent lawsuit on Wednesday in Delaware federal court from Northwestern University, which accused ...

BioPharma Dive2d

Starboard makes case for change at Pfizer, citing research, M&A missteps

The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process, destroyed tens of billions of dollars in market value.

Hosted on MSN9d

What to Expect From Pfizer's Q3 2024 Earnings Report

Valued at a market cap of $164.8 billion, Pfizer Inc. (PFE) discovers, manufactures, distributes, and markets medicines and ...

BioSpace8d

Novavax Shares Slide as FDA Pauses COVID/Flu Vaccine Candidates

The clinical hold affects Novavax’s COVID-flu combo and standalone flu vaccines, which were on the cusp of Phase III testing.

cidrap.umn1d

Can COVID vaccines induce mucosal immunity? Two studies offer conflicting findings

Experiments with mice that received repeated mRNA vaccination showed evidence of neutralizing antibody–producing cells in the ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results